Post by
RichieRich123 on Aug 12, 2020 10:47pm
Why is the company silent about Roswell?
what is the reason?
Is it Sheri's IP or ours?
SILENCE implies what???????
Anyone please - what would be the reason not to release this news?
Comment by
StevenBirch on Aug 13, 2020 7:47am
What news? Stop trying to stir it up.
Comment by
RichieRich123 on Aug 13, 2020 7:50am
What news? re: Roswell. Thank you...you exactly made my point.
Comment by
Longholder99 on Aug 13, 2020 8:04am
I dont even see these posts. Have had most of these names on 'ignore' for months. Works very nicely.
Comment by
StevenBirch on Aug 13, 2020 10:45am
Good point, I guess I missed one.
Comment by
Aubrey on Aug 13, 2020 4:49pm
All I read was Lumeda testing TLD-433 .on a bench top... inviro on lung cancer cells. What else is going on? ..link?
Comment by
Quattro74 on Aug 13, 2020 6:53pm
I think the hope/speculation is that they might license 1433 or maybe do a phase 1 study using it, on their dime instead of TLTs.
Comment by
skier59 on Aug 13, 2020 9:06pm
Yup, have to agree with all of that.....that would be a smart move.
Comment by
tdon1229 on Aug 14, 2020 1:12am
In the absence of any licensing agreement, it's not Theralase's place to report on what Roswell Park might be doing. That's RP's place to report on their own activities ... or not report on it. Theralase seemingly has all it can do to report on its own work. it's not material until it's material.
Comment by
Oilminerdeluxe on Aug 14, 2020 8:08am
That would be a nice thing to see something develop with Roswell. But when is probably impossible to say. Tomorrow, 2022, it could be a while. On the other hand, they must have played around withTLD-1433 for some time now
Comment by
Hankerchief on Aug 14, 2020 9:46am
Roswell Park CC can really come out of this looking good. If they move towards using xray/IV TLD 1433/Rutherrin it could open the door for a wide range of cancer types treated. They seem to know what they are doing. Get it done.